A Look Back at the Past Decade of European Biotech
As we prepare to enter a new decade, we look back on the major milestones…
30/12/2020 - 15 minutes
Phage therapy
Enemy or Valuable Ally? How Biotech Uses Viruses for Good
Taking advantage of the ability of viruses to manipulate life is opening new doors for…
21/12/2020 - 7 minutes
Pluristem Scores €50M From EIB to Develop Covid-19 Cell Therapy
Israeli cell therapy biotech Pluristem Therapeutics has secured up to €50M in non-dilutive funding from…
29/04/2020 - 3 minutes
Can Phage Therapy Answer the Booming Antibiotic Resistance Problem?
Antibiotic-resistant superbugs cause a large number of deaths around the world each year, but effective…
22/04/2020 - 8 minutes
Austrian Biotech Will Develop Viral Protein For Vaginal Infection
The Austrian biotech company PhagoMed Biopharma is developing a viral protein that could one day…
22/10/2019 - 3 minutes
Microbiome Biotech Will Use Series B to Bring Treatments to Clinic
The Israeli biotech BiomX has raised €28M ($32M) to advance its treatments for acne and…
21/02/2019 - 2 minutes
Genentech and Immunocore Expand Partnership to Develop Cancer Immunotherapy
Immunocore and the US biotech giant Genentech are building on their existing partnership to boost…
20/11/2018 - 2 minutes
Could These Groundbreaking Therapies Make Conventional Antibiotics a Thing of the Past?
With the rise of antimicrobial resistance across the globe, and with a dire lack of…
25/07/2018 - 5 minutes
Do Phages Hold the Key to Modulating the Microbiome?
The human microbiome is emerging as a target for treating a wide range of diseases,…
21/03/2018 - 3 minutes
German Biotech Starts Trials with a Personalized Cell Therapy for Multiple Cancers
Immatics will start a first clinical trial to test IMA101, a personalized cell therapy with…
21/08/2017 - 3 minutes
The next generation of Antibiotics could be Bacteriophages
One of the last remaining bastions for organic chemists in pharmaceuticals is in antibiotic development.…
13/09/2016 - 3 minutes
The First Ever Oncolytic Immunotherapy is Set to Reach the European Market
Amgen is now months away from a European approval with Imlygic (also known as T-VEC) - the…
26/10/2015 - 2 minutes
